Cross-border Rx : pharmaceutical manufacturers and U.S. international tax policy : hearing before the Committee on Finance, United States Senate, One Hundred Eighteenth Congress, first session, May 11, 2023.

Format:

Book

Government document

Author/Creator:

United States. Congress. Senate. Committee on Finance, author.

Series:

United States. Congress. Senate. S. hrg. ; 118-590.

S. hrg. ; 118-590

Language:

English

Subjects (All):

Drugs--Prices--United States.

Drugs.

Pharmaceutical industry--United States.

Pharmaceutical industry.

Prescription pricing--United States.

Prescription pricing.

Taxation--United States.

Taxation.

Genre:

Legislative hearings.

Physical Description:

1 online resource (iii, 110 pages) : illustrations.

Other Title:

Pharmaceutical manufacturers and U.S. international tax policy

Place of Publication:

Washington : U.S. Government Publishing Office, 2025.

Participant:

Hearing witnesses: Setser, Brad W., Whitney Shepherdson senior fellow, Council on Foreign Relations, Washington, DC; Bunn, Daniel, president and CEO, Tax Foundation, Washington, DC; Ring, Diane M., professor of law, Boston College Law School, Boston, MA; Morris, William H., deputy global tax policy leader, PwC, Washington, DC.

Notes:

In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I); not distributed in this format as part of the Federal Depository Library Program (FDLP).

Associated bill citation(s): H.R. 1; H.R. 5376.

Includes bibliographical references.

Date of hearing: 2023-05-11.

Description based on online resource; title from PDF title page (GovInfo, viewed May 5, 2025).

Other Format:

Print version: United States. Congress. Senate. Committee on Finance. Cross-border Rx

OCLC:

1518428514

Publisher Number:

59-577 (GPO jacket number)